Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT06952803 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE3 |
| Target Enrollment | 700 participants |
| Active Locations | 45 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 14, 2026 (2 days ago) |
As of October 16, 2026: Clinical trial NCT06952803 is currently recruiting participants. This phase3 study for prostate cancer is actively seeking new participants at 45 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06952803 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 45 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06952803 was last updated 2 days ago (October 14, 2026). HelloStudys verifies this status automatically.